NYXH Stock Nasdaq

Stocks

End-of-day quote Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

22-05-10	Nyxoah's Q1 Loss Widens, Revenue Increases	MT
22-04-21	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT

22-05-10	Nyxoah's Q1 Loss Widens, Revenue Increases	MT
22-04-21	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT
22-04-06	Wolfe Research Starts Nyxoah at Peer Perform With $21 Price Target	MT
22-03-28	Piper Sandler Adjusts Price Target on Nyxoah to $30 From $40, Reiterates Overweight Rating	MT
21-10-05	NYXH : Nyxoah's Genio System Obtains CE-Mark Indication Approval to Treat Complete Concentric Collapse	MT
21-09-14	NYXH : Nyxoah Secures Breakthrough Therapy Designation for Genio Nerve Stimulation Device	MT
21-08-31	NYXH : Nyxoah Reports Wider Loss in H1	MT
21-07-27	NYXH : Stifel Initiates Nyxoah With Buy Rating	MT
21-07-02	NYXH : Belgium's Nyxoah Shares Rise in Stock Market Debut	MT
21-07-02	NYXH : Nyxoah Prices US IPO at $30 Per Share	MT

22-04-21	Oppenheimer Starts Nyxoah at Outperform With $30 Price Target	MT
22-04-06	Wolfe Research Starts Nyxoah at Peer Perform With $21 Price Target	MT
22-03-28	Piper Sandler Adjusts Price Target on Nyxoah to $30 From $40, Reiterates Overweight Rating	MT
21-07-27	NYXH : Stifel Initiates Nyxoah With Buy Rating	MT

22-05-09	Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Premier Trimestre 2022
22-05-06	Nyxoah nomme Raymond Cohen et Virginia Kirby pour la nomination à son Conseil d'Administration
22-04-28	Nyxoah Publiera ses Résultats Financiers pour le Premier Trimestre le 9 mai et Organisera une Conférence Téléphonique le 10 mai 2022
22-03-10	Nyxoah Participera à la 32ème Oppenheimer Annual Healthcare Conference
22-03-07	Nyxoah présentera les données de BETTER SLEEP et organisera des événements pour les médecins lors du World Sleep Congress 2022

Employees

Sector